Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cohort study enrolled high-risk Hodgkin Lymphoma patients in first relapse after induction therapy followed after remission either with a systemic imaging-based surveillance (Imaging cohort) or with standard clinical-based surveillance (standard cohort).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard cohort | Clinical-based surveillance after first complete remission in High risk Hodgkin Lymphoma patients:
|
| |
| Imaging cohort | Clinical-based surveillance after first complete remission in High risk Hodgkin Lymphoma patients:
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Standard cohort: Clinical lab follow-up | Diagnostic Test |
| ||
| Imaging cohort: integrated imaging follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Event Free Survival (EFS) | Events:
| Time period from the first relapse after induction therapy to the date of an event (refractoriness, relapse, or death) or the last follow-up visit after autologous stem cell transplantation (ASCT), up to 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| EFS for clinically silent relapses | Events:
| Time period from the first relapse after induction therapy to the date of an event (refractoriness, relapse, or death) or the last follow-up visit after autologous stem cell transplantation (ASCT), up to 2 years |
| Response rate |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Standard cohort: patients followed-up at the Santa Maria Loreto Mare Hospital Imaging cohort: patients followed-up at the University of Naples Federico II
Not provided
| ID | Term |
|---|---|
| D006689 | Hodgkin Disease |
| D012008 | Recurrence |
| ID | Term |
|---|---|
| D008223 | Lymphoma |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D008232 | Lymphoproliferative Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
| Diagnostic Test |
|
Rate of response |
| After salvage therapy and autologous stem cell transplantation (ASCT), up to 2 years |
| D008206 |
| Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |